| scholarly article | Q13442814 |
| P2093 | author name string | Elif I Ekinci | |
| Sandra L Neoh | |||
| Cecilia Pham | |||
| Nicola Fleming | |||
| Lori J Sacks | |||
| P2860 | cites work | Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China | Q83767469 |
| Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia | Q84108313 | ||
| Evaluating barriers to adopting telemedicine worldwide: A systematic review | Q47740099 | ||
| High glucose modulates IL-6 mediated immune homeostasis through impeding neutrophil extracellular trap formation | Q50937785 | ||
| Circulating ACE2 activity is increased in patients with type 1 diabetes and vascular complications | Q51374898 | ||
| Angiotensin converting enzyme 2 activity and human atrial fibrillation: increased plasma angiotensin converting enzyme 2 activity is associated with atrial fibrillation and more advanced left atrial structural remodelling. | Q51396354 | ||
| Plasma glucose levels and diabetes are independent predictors for mortality and morbidity in patients with SARS. | Q51496846 | ||
| Elevated plasma angiotensin converting enzyme 2 activity is an independent predictor of major adverse cardiac events in patients with obstructive coronary artery disease. | Q55409649 | ||
| The influence of increasing glucose concentrations on selected functions of polymorphonuclear neutrophils | Q68065710 | ||
| Inhibition of polymorphonuclear leukocyte respiratory burst by elevated glucose concentrations in vitro | Q69665463 | ||
| Impaired leucocyte functions in diabetic patients | Q73032290 | ||
| A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase | Q22254730 | ||
| Interactive telemedicine: effects on professional practice and health care outcomes | Q24187302 | ||
| Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance | Q28131660 | ||
| Depression and poor glycemic control: a meta-analytic review of the literature | Q28140847 | ||
| Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators | Q28144781 | ||
| Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes | Q28188162 | ||
| Prevalence of Diabetes in the 2009 Influenza A (H1N1) and the Middle East Respiratory Syndrome Coronavirus: A Systematic Review and Meta-Analysis | Q28357789 | ||
| Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy | Q29615215 | ||
| Adipose tissue as an endocrine organ | Q29620407 | ||
| Stress hyperglycemia, insulin treatment, and innate immune cells. | Q33668059 | ||
| Structure, Function, and Evolution of Coronavirus Spike Proteins | Q33760875 | ||
| IL-6 in inflammation, immunity, and disease | Q34248105 | ||
| Angiotensin II mediates angiotensin converting enzyme type 2 internalization and degradation through an angiotensin II type I receptor-dependent mechanism. | Q34510691 | ||
| Associations between psychological stress, eating, physical activity, sedentary behaviours and body weight among women: a longitudinal study | Q34983028 | ||
| Anxiety and poor glycemic control: a meta-analytic review of the literature. | Q35029384 | ||
| The influence of pre-existing diabetes mellitus on the host immune response and outcome of pneumonia: analysis of two multicentre cohort studies | Q35835962 | ||
| MAP kinase/phosphatase pathway mediates the regulation of ACE2 by angiotensin peptides | Q36977764 | ||
| Role of the ACE2/Angiotensin 1-7 Axis of the Renin-Angiotensin System in Heart Failure | Q37081415 | ||
| Diabetes and infection: is there a link?--A mini-review. | Q38062723 | ||
| ACE2, angiotensin-(1–7), and Mas: the other side of the coin | Q38086829 | ||
| Diabetes and infection: assessing the association with glycaemic control in population-based studies | Q38666111 | ||
| The Effect of Short-Term Hyperglycemia on the Innate Immune System | Q38742052 | ||
| Tissue resident macrophages: Key players in the pathogenesis of type 2 diabetes and its complications | Q38939559 | ||
| Leukocyte-endothelial interaction is augmented by high glucose concentrations and hyperglycemia in a NF-kB-dependent fashion | Q39466560 | ||
| Combination renin-angiotensin system blockade and angiotensin-converting enzyme 2 in experimental myocardial infarction: implications for future therapeutic directions | Q39599579 | ||
| The association between diabetes mellitus and incident infections: a systematic review and meta-analysis of observational studies | Q40100295 | ||
| Angiotensin-converting enzyme 2 catalytic activity in human plasma is masked by an endogenous inhibitor. | Q40130425 | ||
| Influence of Intermittent Hyperglycemic Glucose Levels on the Phagocytosis of Microorganisms by Human Granulocytes in Vitro | Q41005809 | ||
| Telehealth and patient satisfaction: a systematic review and narrative analysis | Q42081760 | ||
| Upregulation of angiotensin-converting enzyme 2 after myocardial infarction by blockade of angiotensin II receptors | Q44790566 | ||
| Myocardial infarction increases ACE2 expression in rat and humans. | Q45238600 | ||
| Effects of diabetes mellitus vs. in vitro hyperglycemia on select immune cell functions. | Q45973146 | ||
| Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2. | Q46493539 | ||
| Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China | Q84574466 | ||
| Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study | Q87191917 | ||
| Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study | Q87412594 | ||
| Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? | Q87812699 | ||
| Telemedicine in Complex Diabetes Management | Q88802881 | ||
| Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China | Q89796088 | ||
| Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention | Q89855853 | ||
| China cardiovascular diseases report 2018: an updated summary | Q90055257 | ||
| Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China | Q90251707 | ||
| Comorbid diabetes results in immune dysregulation and enhanced disease severity following MERS-CoV infection | Q90255332 | ||
| A Review of Coronavirus Disease-2019 (COVID-19) | Q90288631 | ||
| Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State | Q90455461 | ||
| Comorbidity and its impact on 1590 patients with Covid-19 in China: A Nationwide Analysis | Q90689077 | ||
| Covid-19 in Critically Ill Patients in the Seattle Region - Case Series | Q90754566 | ||
| Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19 | Q90754574 | ||
| Diabetes is a risk factor for the progression and prognosis of COVID-19 | Q90788181 | ||
| Distal technology interventions in people with diabetes: an umbrella review of multiple health outcomes | Q90831148 | ||
| Type 2 Diabetes and its Impact on the Immune System | Q90968084 | ||
| Spectrum of clinical and radiographic findings in patients with diagnosis of H1N1 and correlation with clinical severity | Q91257083 | ||
| Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy | Q91588064 | ||
| COVID-19, Australia: Epidemiology Report 10 (Reporting week to 23:59 AEST 5 April 2020) | Q91736216 | ||
| SGLT2 Inhibitors Increase the Risk of Diabetic Ketoacidosis Developing in the Community and During Hospital Admission | Q92137803 | ||
| Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes | Q94540668 | ||
| Association of the insulin resistance marker TyG index with the severity and mortality of COVID-19 | Q94559954 | ||
| Glycemic Characteristics and Clinical Outcomes of COVID-19 Patients Hospitalized in the United States | Q94598752 | ||
| The Clinical Characteristics and Outcomes of Diabetes Mellitus and Secondary Hyperglycaemia Patients with Coronavirus Disease 2019: a Single-center, Retrospective, Observational Study in Wuhan | Q94677216 | ||
| Glycosylated hemoglobin is associated with systemic inflammation, hypercoagulability, and prognosis of COVID-19 patients | Q94950743 | ||
| Patients with diabetes are at higher risk for severe illness from COVID-19 | Q94951194 | ||
| P921 | main subject | COVID-19 | Q84263196 |
| COVID-19 pandemic | Q81068910 | ||
| P304 | page(s) | 108296 | |
| P577 | publication date | 2020-07-02 | |
| P1433 | published in | Diabetes Research and Clinical Practice | Q15750054 |
| P1476 | title | Considerations for people with diabetes during the Coronavirus Disease (COVID-19) Pandemic |
Search more.